Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.5M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
6.4M
-
Shares change
-
+502K
-
Total reported value, excl. options
-
$5.76M
-
Value change
-
+$306K
-
Number of buys
-
30
-
Number of sells
-
-17
-
Price
-
$0.90
Significant Holders of FibroBiologics, Inc. - Common Stock (FBLG) as of Q1 2025
69 filings reported holding FBLG - FibroBiologics, Inc. - Common Stock as of Q1 2025.
FibroBiologics, Inc. - Common Stock (FBLG) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.4M shares
of 37.5M outstanding shares and own 17.04% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.77M shares), VANGUARD GROUP INC (1.42M shares), GEODE CAPITAL MANAGEMENT, LLC (615K shares), STATE STREET CORP (566K shares), Cascade Financial Partners, LLC (260K shares), NORTHERN TRUST CORP (206K shares), UBS Group AG (113K shares), Optivise Advisory Services LLC (110K shares), Requisite Capital Management, LLC (110K shares), and Cerity Partners LLC (93.4K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.